Home » news »

Scientists rise new drug that combats dual ‘priority pathogens’

 

Posted in: Device / Technology News | Medical Research News | Pharmaceutical News

Tags: Acinetobacter, Acinetobacter Baumannii, Antibiotic, Antibiotic Resistance, Antimicrobial Resistance, Bacteria, Campylobacter, Chlamydia, Drugs, Enterococcus, Fluoroquinolone, Genomic, Helicobacter pylori, Hospital, Infectious Diseases, Nutrition, Pathogen, Pathophysiology, Pharmacology, Physiology, Proliferation, Public Health, Respiratory, Staphylococcus aureus, Toxicology